Key facts
- Notable investors include NRL Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhiweituo Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhiweituo Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhiweituo Pharmaceutical
Manufacturer of oral small-molecule therapeutics and pharmaceuticals intended for autoimmune disease treatment. The company offers interactive molecular design system with proprietary wet-lab validation capabilities, enabling the biopharmaceutical market to accelerate lead compound discovery, enhance molecular optimization efficiency, and address previously intractable targets with improved development speed, scalability, and therapeutic precision.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Zhiweituo Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhiweituo Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhiweituo Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.